Greenspan G H, Block A J, Haldeman L W, Lindsey S, Martin C S
Chest. 1981 Oct;80(4):442-6. doi: 10.1378/chest.80.4.442.
We evaluated the accuracy of a new device for continuous noninvasive measurement of cutaneous PCO2. The Hewlett-Packard capnometer (model 47210/HA) works by means of an infrared transducer applied to the forearm over an area of skin that has been stripped of the stratum corneum. Capnometer transcutaneous carbon dioxide pressure (CPCO2) was compared with arterial carbon dioxide pressure (PaCO2) during 60 simultaneously obtained measurements in 13 hemodynamically stable patients. Each patient was studied for 1 1/2 to 5 hours, and a wide range of PaCO2 values (21 to 82 mm Hg) was represented. The data show a clinically significant relationship whereby PaCO2 = CPCO2 - 4.13, with a SE of +/- 2.19 mm Hg. Clinical usefulness of noninvasive cutaneous CO2 monitoring can be foreseen in patients whose ventilatory support is being tapered, in those with respiratory depression caused by various neuromuscular disorders, and in patients with chronic obstructive pulmonary disease and acute respiratory failure. Our results indicate that continuous transcutaneous CPCO2 measurements are safe and accurate and strongly suggest that they can be of clinical usefulness in a select group of hemodynamically stable patients.
我们评估了一种用于连续无创测量皮肤二氧化碳分压(PCO2)的新设备的准确性。惠普二氧化碳监测仪(型号47210/HA)通过将红外传感器应用于已去除角质层的前臂皮肤区域来工作。在对13名血流动力学稳定的患者进行的60次同步测量中,比较了二氧化碳监测仪的经皮二氧化碳压力(CPCO2)与动脉二氧化碳压力(PaCO2)。对每位患者进行了1.5至5小时的研究,涵盖了广泛的PaCO2值范围(21至82毫米汞柱)。数据显示出一种具有临床意义的关系,即PaCO2 = CPCO2 - 4.13,标准误为±2.19毫米汞柱。在通气支持逐渐减少的患者、由各种神经肌肉疾病引起呼吸抑制的患者以及患有慢性阻塞性肺疾病和急性呼吸衰竭的患者中,可以预见无创皮肤二氧化碳监测的临床实用性。我们的结果表明,连续经皮CPCO2测量是安全且准确的,并强烈提示它们在一组血流动力学稳定的特定患者中可能具有临床实用性。